Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries

BACKGROUND: Mucopolysaccharidosis IVA (MPS IVA), or Morquio A syndrome, is a rare inherited metabolic disorder caused by deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase. A progressive systemic skeletal chondrodysplasia, leading to significant morbidity and reduced life expectanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Magner, Martin, Almássy, Zsuzsanna, Gucev, Zoran, Kieć-Wilk, Beata, Plaiasu, Vasilica, Tylki-Szymańska, Anna, Zafeiriou, Dimitrios, Zaganas, Ioannis, Lampe, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092811/
https://www.ncbi.nlm.nih.gov/pubmed/35538504
http://dx.doi.org/10.1186/s13023-022-02332-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092811/
https://www.ncbi.nlm.nih.gov/pubmed/35538504
http://dx.doi.org/10.1186/s13023-022-02332-7

Ejemplares similares